These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19383924)

  • 1. Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia.
    Scholl FA; Dumesic PA; Barragan DI; Harada K; Charron J; Khavari PA
    Cancer Res; 2009 May; 69(9):3772-8. PubMed ID: 19383924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
    Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
    Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lgr4 is crucial for skin carcinogenesis by regulating MEK/ERK and Wnt/β-catenin signaling pathways.
    Xu P; Dang Y; Wang L; Liu X; Ren X; Gu J; Liu M; Dai X; Ye X
    Cancer Lett; 2016 Dec; 383(2):161-170. PubMed ID: 27693558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
    Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
    Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Leydig cell MEK/ERK pathway is critical for maintaining a functional population of adult Leydig cells and for fertility.
    Yamashita S; Tai P; Charron J; Ko C; Ascoli M
    Mol Endocrinol; 2011 Jul; 25(7):1211-22. PubMed ID: 21527500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mek1 alters epidermal growth and differentiation.
    Scholl FA; Dumesic PA; Khavari PA
    Cancer Res; 2004 Sep; 64(17):6035-40. PubMed ID: 15342384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of MEK2 is sufficient to induce skin papilloma formation in transgenic zebrafish.
    Chou CM; Chen YC; Su S; Chen GD; Huang KY; Lien HW; Huang CJ; Cheng CH
    J Biomed Sci; 2015 Nov; 22():102. PubMed ID: 26572230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis.
    Bourcier C; Jacquel A; Hess J; Peyrottes I; Angel P; Hofman P; Auberger P; Pouysségur J; Pagès G
    Cancer Res; 2006 Mar; 66(5):2700-7. PubMed ID: 16510590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early epidermal destruction with subsequent epidermal hyperplasia is a unique feature of the papilloma-independent squamous cell carcinoma phenotype in PKCepsilon overexpressing transgenic mice.
    Li Y; Wheeler DL; Alters W; Chaiswing L; Verma AK; Oberley TD
    Toxicol Pathol; 2005; 33(6):684-94. PubMed ID: 16243773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of skin tumorigenesis in CD109-deficient mice.
    Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
    Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK1/2 can feedback-regulate cellular MEK1/2 levels.
    Hong SK; Wu PK; Karkhanis M; Park JI
    Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JWA deficiency suppresses dimethylbenz[a]anthracene-phorbol ester induced skin papillomas via inactivation of MAPK pathway in mice.
    Gong Z; Shi Y; Zhu Z; Li X; Ye Y; Zhang J; Li A; Li G; Zhou J
    PLoS One; 2012; 7(3):e34154. PubMed ID: 22461904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional redundancy of the kinases MEK1 and MEK2: Rescue of the Mek1 mutant phenotype by Mek2 knock-in reveals a protein threshold effect.
    Aoidi R; Maltais A; Charron J
    Sci Signal; 2016 Jan; 9(412):ra9. PubMed ID: 26814233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of benzo[a]pyrene-initiated mouse skin papillomas for Ha-ras mutations and protein kinase C levels.
    Colapietro AM; Goodell AL; Smart RC
    Carcinogenesis; 1993 Nov; 14(11):2289-95. PubMed ID: 8242857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in protein kinase C isozymes alpha and beta 2 in activated Ha-ras containing papillomas in the absence of an increase in diacylglycerol.
    Mills KJ; Bocckino SB; Burns DJ; Loomis CR; Smart RC
    Carcinogenesis; 1992 Jul; 13(7):1113-20. PubMed ID: 1638676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal.
    Catalanotti F; Reyes G; Jesenberger V; Galabova-Kovacs G; de Matos Simoes R; Carugo O; Baccarini M
    Nat Struct Mol Biol; 2009 Mar; 16(3):294-303. PubMed ID: 19219045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
    Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
    Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
    Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
    Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of protein kinase Calpha in mice results in impairment of epidermal hyperplasia and enhancement of tumor formation in two-stage skin carcinogenesis.
    Hara T; Saito Y; Hirai T; Nakamura K; Nakao K; Katsuki M; Chida K
    Cancer Res; 2005 Aug; 65(16):7356-62. PubMed ID: 16103087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.